La Maison season 1 episode 7, titled La Vie en Rose, dropped on Apple TV+ on Friday, October 25, 2024. As the French drama nears its conclusion, the latest installment of the series raises its ...
Almost every scene of the powerful "La Cocina" takes place in or just outside the kitchen of a Times Square tourist trap bluntly dubbed The Grill. It's one of those places that does a bit of ...
After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. In a new deal potentially worth more than $1 billion, Roche is paying Dyno $50 million upfront to ...
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy delivery technology, which synthesizes virus capsids with better functionality ...
Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...
Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...
Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...
Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...
Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...
FRANKFURT, Oct 23 (Reuters) - The CEO of Roche (ROG.S), opens new tab said he has been informed that more cases of mpox infection have occurred in Europe than previously reported and that the ...
Its white wines, made from chardonnay grapes, highlight the richness of Mâcon La Roche Vineuse and Saint ... estate begins with the château's striking exterior, showcasing the architectural ...
UCB will advance its anti-tau antibody for Alzheimer’s disease solo after Roche and Genentech walked away from the asset known as bepranemab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback